Brought to you by 
Kinetic Concepts pays $1.7bn in cash for LifeCell
03 Nov 2020
Executive Summary
Kinetic Concepts (KCI; wound healing devices and therapeutic support beds and surfaces) has agreed to pay $1.7bn cash (or $51 per share, a 19% premium) to acquire all of publicly owned LifeCell's (regenerative tissue repair) 34mm outstanding shares.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com